Cargando…
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammato...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208021/ https://www.ncbi.nlm.nih.gov/pubmed/37304240 http://dx.doi.org/10.32604/or.2023.028163 |
_version_ | 1785046581670576128 |
---|---|
author | VILLOLDO, GUSTAVO MARTÍN POMBO, MARÍA TERESA ARIS, MARIANA CHEMI, JOAQUÍN MANDÓ, PABLO NAGARAJU, SUPRIYA CAMEAN, JUAN BURIONI, ADRIÁN EGEA, DEBORAH AMAT, MORA MELLADO, JOSÉ LEÓN MORDOH, JOSÉ VILLARONGA, ALBERTO BARRIO, MARÍA MARCELA |
author_facet | VILLOLDO, GUSTAVO MARTÍN POMBO, MARÍA TERESA ARIS, MARIANA CHEMI, JOAQUÍN MANDÓ, PABLO NAGARAJU, SUPRIYA CAMEAN, JUAN BURIONI, ADRIÁN EGEA, DEBORAH AMAT, MORA MELLADO, JOSÉ LEÓN MORDOH, JOSÉ VILLARONGA, ALBERTO BARRIO, MARÍA MARCELA |
author_sort | VILLOLDO, GUSTAVO MARTÍN |
collection | PubMed |
description | Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammatory cells (Th1) and ultimately cytotoxic tumor elimination. We searched for predictive biomarker of BCG response by analyzing tumor-infiltrating lymphocyte (TIL) polarization in the tumor microenvironment (TME) in pre-treatment biopsies. Pre-treatment biopsies from patients with NMIBC who received adequate intravesical instillation of BCG (n = 32) were evaluated retrospectively by immunohistochemistry. TME polarization was assessed by quantifying the T-Bet+ (Th1) and GATA-3+ (Th2) lymphocyte ratio (G/T), and the density and degranulation of EPX+ eosinophils. In addition, PD-1/PD-L1 staining was quantified. The results correlated with BCG response. In most non-responders, Th1/Th2 markers were compared in pre-and post-BCG biopsies. ORR was 65.6% in the study population. BCG responders had a higher G/T ratio and a greater number of degranulated EPX+ cells. Variables combined into a Th2-score showed a significant association with higher scores in responders (p = 0.027). A Th2-score cut-off value >48.1 allowed discrimination of responders with 91% sensitivity but lower specificity. Relapse-free survival was significantly associated with the Th2-score (p = 0.007). In post-BCG biopsies from recurring patients, TILs increased Th2-polarization, probably reflecting BCG failure to induce a pro-inflammatory status and, thus, a lack of response. PD-L1/PD-1 expression was not associated with the response to BCG. Our results support the hypothesis that a pre-existing Th2-polarized TME predicts a better response to BCG, assuming a reversion to Th1 polarization and antitumor activity. |
format | Online Article Text |
id | pubmed-10208021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Tech Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102080212023-06-10 A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study VILLOLDO, GUSTAVO MARTÍN POMBO, MARÍA TERESA ARIS, MARIANA CHEMI, JOAQUÍN MANDÓ, PABLO NAGARAJU, SUPRIYA CAMEAN, JUAN BURIONI, ADRIÁN EGEA, DEBORAH AMAT, MORA MELLADO, JOSÉ LEÓN MORDOH, JOSÉ VILLARONGA, ALBERTO BARRIO, MARÍA MARCELA Oncol Res Article Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammatory cells (Th1) and ultimately cytotoxic tumor elimination. We searched for predictive biomarker of BCG response by analyzing tumor-infiltrating lymphocyte (TIL) polarization in the tumor microenvironment (TME) in pre-treatment biopsies. Pre-treatment biopsies from patients with NMIBC who received adequate intravesical instillation of BCG (n = 32) were evaluated retrospectively by immunohistochemistry. TME polarization was assessed by quantifying the T-Bet+ (Th1) and GATA-3+ (Th2) lymphocyte ratio (G/T), and the density and degranulation of EPX+ eosinophils. In addition, PD-1/PD-L1 staining was quantified. The results correlated with BCG response. In most non-responders, Th1/Th2 markers were compared in pre-and post-BCG biopsies. ORR was 65.6% in the study population. BCG responders had a higher G/T ratio and a greater number of degranulated EPX+ cells. Variables combined into a Th2-score showed a significant association with higher scores in responders (p = 0.027). A Th2-score cut-off value >48.1 allowed discrimination of responders with 91% sensitivity but lower specificity. Relapse-free survival was significantly associated with the Th2-score (p = 0.007). In post-BCG biopsies from recurring patients, TILs increased Th2-polarization, probably reflecting BCG failure to induce a pro-inflammatory status and, thus, a lack of response. PD-L1/PD-1 expression was not associated with the response to BCG. Our results support the hypothesis that a pre-existing Th2-polarized TME predicts a better response to BCG, assuming a reversion to Th1 polarization and antitumor activity. Tech Science Press 2023-04-10 /pmc/articles/PMC10208021/ /pubmed/37304240 http://dx.doi.org/10.32604/or.2023.028163 Text en © 2023 Villoldo et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article VILLOLDO, GUSTAVO MARTÍN POMBO, MARÍA TERESA ARIS, MARIANA CHEMI, JOAQUÍN MANDÓ, PABLO NAGARAJU, SUPRIYA CAMEAN, JUAN BURIONI, ADRIÁN EGEA, DEBORAH AMAT, MORA MELLADO, JOSÉ LEÓN MORDOH, JOSÉ VILLARONGA, ALBERTO BARRIO, MARÍA MARCELA A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study |
title | A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study |
title_full | A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study |
title_fullStr | A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study |
title_full_unstemmed | A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study |
title_short | A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study |
title_sort | th2-score in the tumor microenvironment as a predictive biomarker of response to bacillus calmette guérin in patients with non-muscle invasive bladder carcinoma: a retrospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208021/ https://www.ncbi.nlm.nih.gov/pubmed/37304240 http://dx.doi.org/10.32604/or.2023.028163 |
work_keys_str_mv | AT villoldogustavomartin ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT pombomariateresa ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT arismariana ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT chemijoaquin ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT mandopablo ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT nagarajusupriya ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT cameanjuan ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT burioniadrian ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT egeadeborah ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT amatmora ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT melladojoseleon ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT mordohjose ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT villarongaalberto ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT barriomariamarcela ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT villoldogustavomartin th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT pombomariateresa th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT arismariana th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT chemijoaquin th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT mandopablo th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT nagarajusupriya th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT cameanjuan th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT burioniadrian th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT egeadeborah th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT amatmora th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT melladojoseleon th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT mordohjose th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT villarongaalberto th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy AT barriomariamarcela th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy |